GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (LTS:0DTR) » Definitions » Deferred Policy Acquisition Costs

Bioton (LTS:0DTR) Deferred Policy Acquisition Costs


View and export this data going back to 2007. Start your Free Trial

What is Bioton Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Bioton (LTS:0DTR) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (LTS:0DTR) » Definitions » Deferred Policy Acquisition Costs
Traded in Other Exchanges
Address
Ul. Staro?ci?ska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.